Fundraising FoxAcousia
Tübingen, DE · 6 known investors
Find your way into Acousia
Sign up to see every warm intro you have to Acousia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Acousia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acousia Therapeutics develops small-molecule drug candidates with a dual mode of action for treating acute and chronic sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear to preserve and enhance natural hearing. The biotech company focuses on drug therapies as a first-line or complementary option to hearing aids and cochlear implants.
Founders & leadership
Investors · 6
How we know: the company's own site · funding news · hearingreview.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · funding news · hearingreview.com · Not right? Tell us
How we know: Creathor Ventures's portfolio page · hearingreview.com · Not right? Tell us
How we know: hearingreview.com · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMay 2018
LBBW Venture Capital (lead), Boehringer Ingelheim Venture Fund (BIVF), Bregua Corporation, Creathor Ventures, Kreditanstalt für Wiederaufbau (KfW)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Acousia do?
- Acousia Therapeutics develops small-molecule drug candidates with a dual mode of action for treating acute and chronic sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear to preserve and enhance natural hearing. The biotech company focuses on drug therapies as a first-line or complementary option to hearing aids and cochlear implants.
- Who founded Acousia?
- Acousia was founded by Hubert Löwenheim.
- Who are Acousia's investors?
- Acousia's investors include Boehringer Ingelheim Venture Fund, KfW, Creathor Ventures, LBBW Venture Capital GmbH, Esperante Ventures.
- Where is Acousia headquartered?
- Acousia is headquartered in Tübingen, DE.